JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M209523200 on January 14, 2003

J. Biol. Chem., Vol. 278, Issue 14, 12443-12451, April 4, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/14/12443    most recent
M209523200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delmas, C.
Right arrow Articles by Manenti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delmas, C.
Right arrow Articles by Manenti, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

MAP Kinase-dependent Degradation of p27Kip1 by Calpains in Choroidal Melanoma Cells
REQUIREMENT OF p27Kip1 NUCLEAR EXPORT*

Christelle Delmas, Nathalie Aragou, Sylvie PoussardDagger , Patrick CottinDagger , Jean-Marie Darbon, and Stéphane Manenti§

From the Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, CNRS UMR 5088, IFR 109, Université Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex, France and the Dagger  Laboratoire Biochimie et Technologie des Aliments USC-INRA 429, Université Bordeaux I, Avenue des Facultés, 33405 Talence Cedex, France

We investigated the status and the regulation of the cyclin-dependent kinases (CDK) inhibitor p27Kip1 in a choroidal melanoma tumor-derived cell line (OCM-1). By contrast to normal choroidal melanocytes, the expression level of p27Kip1 was low in these cells and the mitogen-activated protein (MAP) kinase pathway was constitutively activated. Genetic or chemical inhibition of this pathway induced p27Kip1 accumulation, whereas MAP kinase reactivation triggered a down-regulation of p27Kip1 that could be partially reversed by calpain inhibitors. In good accordance, ectopic expression of the cellular calpain inhibitor calpastatin led to an increase of endogenous p27Kip1 expression. In vitro, p27Kip1 was degraded by calpains, and OCM-1 cell extracts contained a calcium-dependent p27Kip1 degradation activity. MAP kinase inhibition partially inhibited both calpain activity and calcium-dependent p27Kip1 degradation by cellular extracts. Immunofluorescence labeling and subcellular fractionation revealed that p27Kip1 was in part localized in the cytoplasmic compartment of OCM-1 cells but not of melanocytes, and accumulated into the nucleus upon MAP kinase inhibition. MAP kinase activation triggered a cytoplasmic translocation of the protein, as well as a change in its phosphorylation status. This CRM-1-dependent cytoplasmic translocation was necessary for MAP kinase- and calpain-dependent degradation. Taken together, these data suggest that in tumor-derived cells, p27Kip1 could be degraded by calpains through a MAP kinase-dependent process, and that abnormal cytoplasmic localization of the protein, probably linked to modifications of its phosphorylation state, could be involved in this alternative mechanism of degradation.

* This work was supported by the Centre National de la Recherche Scientifique and the Université Paul Sabatier.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, CNRS UMR 5088, Université Paul Sabatier, Batiment 4R3B1, 118 Route de Narbonne, 31062 Toulouse Cedex, France. Tel.: 33-561-55-69-19; Fax: 33-561-55-81-09; E-mail: manenti@cict.fr.

Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
F. Felicetti, M. C. Errico, L. Bottero, P. Segnalini, A. Stoppacciaro, M. Biffoni, N. Felli, G. Mattia, M. Petrini, M. P. Colombo, et al.
The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms
Cancer Res., April 15, 2008; 68(8): 2745 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
I. T. Makagiansar, S. Williams, T. Mustelin, and W. B. Stallcup
Differential phosphorylation of NG2 proteoglycan by ERK and PKC{alpha} helps balance cell proliferation and migration
J. Cell Biol., October 3, 2007; 178(1): 155 - 165.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T.-N. Zhu, H.-J. He, S. Kole, T. D'Souza, R. Agarwal, P. J. Morin, and M. Bernier
Filamin A-mediated Down-regulation of the Exchange Factor Ras-GRF1 Correlates with Decreased Matrix Metalloproteinase-9 Expression in Human Melanoma Cells
J. Biol. Chem., May 18, 2007; 282(20): 14816 - 14826.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
N. A. Khan, K. Nishimura, V. Aires, T. Yamashita, D. Oaxaca-Castillo, K. Kashiwagi, and K. Igarashi
Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation
J. Lipid Res., October 1, 2006; 47(10): 2306 - 2313.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. Bockstaele, H. Kooken, F. Libert, S. Paternot, J. E. Dumont, Y. de Launoit, P. P. Roger, and K. Coulonval
Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK "Inhibitors".
Mol. Cell. Biol., July 1, 2006; 26(13): 5070 - 5085.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Borriello, V. Cucciolla, M. Criscuolo, S. Indaco, A. Oliva, A. Giovane, D. Bencivenga, A. Iolascon, V. Zappia, and F. Della Ragione
Retinoic Acid Induces p27Kip1 Nuclear Accumulation by Modulating Its Phosphorylation.
Cancer Res., April 15, 2006; 66(8): 4240 - 4248.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Marzia, R. Chiusaroli, L. Neff, N.-Y. Kim, A. H. Chishti, R. Baron, and W. C. Horne
Calpain Is Required for Normal Osteoclast Function and Is Down-regulated by Calcitonin
J. Biol. Chem., April 7, 2006; 281(14): 9745 - 9754.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Fujita, S. Sato, and T. Tsuruo
Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization
J. Biol. Chem., December 5, 2003; 278(49): 49254 - 49260.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Calipel, G. Lefevre, C. Pouponnot, F. Mouriaux, A. Eychene, and F. Mascarelli
Mutation of B-Raf in Human Choroidal Melanoma Cells Mediates Cell Proliferation and Transformation through the MEK/ERK Pathway
J. Biol. Chem., October 24, 2003; 278(43): 42409 - 42418.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Foster, R. I. Fernando, N. Ishida, K. I. Nakayama, and J. Wimalasena
Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway
J. Biol. Chem., October 17, 2003; 278(42): 41355 - 41366.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.